Transgene Biotek Ltd

₹ 2.66 7.69%

12 Oct - close price

About

Incorporated in 1990, Transgene Biotek Ltd
is in the business of Research & Development^[1]

Key Points

Business Overview:^[1]
TBL started as a Biotechnology company engaged in the manufacturing and selling diagnostic kits. The company expanded to biotech research, including the research and development of vaccines, oncology, New drug delivery technologies etc. Currently, the company has a product and technology portfolio covering Oncology, Oral Drug Delivery and Bio-generics.

Website BSE

Market Cap ₹ 20.2 Cr.
Current Price ₹ 2.66
High / Low ₹ 4.39 / 1.83
Stock P/E
Book Value ₹ 1.11
Dividend Yield 0.00 %
ROCE -2.36 %
ROE -17.9 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Cons

Company has low interest coverage ratio.
Promoter holding is low: 23.6%
Company has a low return on equity of -9.77% over last 3 years.
Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	0.10	0.05	0.05	0.05	0.05	0.06	0.08	0.08	0.05	0.05	0.05	0.05	0.06
	0.22	0.17	0.16	0.32	0.46	0.13	0.17	0.62	0.18	0.13	0.10	0.33	0.12
Operating Profit	-0.12	-0.12	-0.11	-0.27	-0.41	-0.07	-0.09	-0.54	-0.13	-0.08	-0.05	-0.28	-0.06
OPM %	-120.00%	-240.00%	-220.00%	-540.00%	-820.00%	-116.67%	-112.50%	-675.00%	-260.00%	-160.00%	-100.00%	-560.00%	-100.00%
	0.04	0.04	0.04	0.05	0.65	0.04	0.04	0.04	0.00	0.00	0.00	0.15	0.00
Interest	0.03	0.03	0.03	0.03	0.02	0.02	0.02	0.19	0.25	0.26	0.27	0.28	0.29
Depreciation	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.05	0.05	0.05	0.05	0.04
Profit before tax	-0.13	-0.13	-0.12	-0.27	0.20	-0.07	-0.09	-0.71	-0.43	-0.39	-0.37	-0.46	-0.39
Tax %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	-0.13	-0.13	-0.12	-0.27	0.20	-0.07	-0.09	-0.71	-0.43	-0.39	-0.37	-0.46	-0.39
EPS in Rs	-0.02	-0.02	-0.02	-0.04	0.03	-0.01	-0.01	-0.09	-0.06	-0.05	-0.05	-0.06	-0.05
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	0.30	0.18	0.28	0.12	0.07	0.00	0.17	0.09	0.06	0.23	0.26	0.21	0.21
	1.90	1.32	2.84	2.22	0.75	0.87	0.70	0.55	0.68	0.83	1.38	0.75	0.68
Operating Profit	-1.60	-1.14	-2.56	-2.10	-0.68	-0.87	-0.53	-0.46	-0.62	-0.60	-1.12	-0.54	-0.47
OPM %	-533.33%	-633.33%	-914.29%	-1,750.00%	-971.43%		-311.76%	-511.11%	-1,033.33%	-260.87%	-430.77%	-257.14%	-223.81%
	0.01	0.17	0.66	7.37	2.04	0.18	0.27	0.21	0.18	0.18	0.78	0.15	0.15
Interest	0.36	0.07	0.43	1.03	0.26	0.38	0.27	0.23	0.62	0.14	0.24	1.06	1.10
Depreciation	17.18	20.50	17.53	9.89	9.89	9.90	9.91	9.92	4.95	0.09	0.09	0.20	0.19
Profit before tax	-19.13	-21.54	-19.86	-5.65	-8.79	-10.97	-10.44	-10.40	-6.01	-0.65	-0.67	-1.65	-1.61
Tax %	0.00%	0.00%	0.00%	13.98%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	-19.14	-21.54	-19.86	-6.44	-8.79	-10.96	-10.43	-10.40	-6.01	-0.66	-0.68	-1.65	-1.61
EPS in Rs	-2.53	-2.84	-2.62	-0.85	-1.16	-1.45	-1.38	-1.37	-0.79	-0.09	-0.09	-0.22	-0.21
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Compounded Sales Growth
10 Years:	2%
5 Years:	4%
3 Years:	52%
TTM:	-22%

Compounded Profit Growth
10 Years:	7%
5 Years:	13%
3 Years:	20%
TTM:	-24%

Stock Price CAGR
10 Years:	1%
5 Years:	-9%
3 Years:	-14%
1 Year:	-36%

Return on Equity
10 Years:	-23%
5 Years:	-30%
3 Years:	-10%
Last Year:	-18%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	75.77	75.77	75.77	75.77	75.77	75.77	75.77	75.77	75.77	75.77	75.77	75.77
Reserves	115.62	98.67	-16.90	-23.34	-32.13	-43.10	-53.53	-58.39	-64.40	-65.06	-65.74	-67.39
	14.43	15.28	16.01	9.84	9.14	10.33	11.33	12.01	13.11	14.00	14.52	17.14
	137.95	123.27	123.18	124.28	123.77	123.75	123.31	117.71	117.87	117.62	119.54	118.14
Total Liabilities	343.77	312.99	198.06	186.55	176.55	166.75	156.88	147.10	142.35	142.33	144.09	143.66
	163.40	140.95	61.16	50.97	41.10	31.20	21.32	11.40	6.45	6.36	7.96	9.63
CWIP	0.29	0.29	2.04	1.87	1.87	1.87	1.87	1.87	1.87	1.87	1.87	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.10	0.10	0.10	0.10	0.09
	180.08	171.75	134.86	133.71	133.58	133.68	133.69	133.73	133.93	134.00	134.16	133.94
Total Assets	343.77	312.99	198.06	186.55	176.55	166.75	156.88	147.10	142.35	142.33	144.09	143.66

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	3.52	6.47	0.02	-0.63	-1.74	0.14	0.01	0.10	0.00	0.00	1.20	-0.01
	-4.57	-6.47	0.00	3.05	1.74	0.00	-0.03	-0.10	-0.01	0.00	-1.70	0.15
	1.03	0.00	0.00	-2.37	0.00	-0.20	0.00	0.00	0.00	0.00	0.78	-0.36
Net Cash Flow	-0.02	0.00	0.02	0.05	0.00	-0.06	-0.01	0.00	-0.01	0.00	0.28	-0.22
Free Cash Flow	-1.05	0.00	0.02	2.74	-0.01	0.14	-0.02	0.10	0.00	0.00	-0.50	0.14
CFO/OP	-220%	-568%	-1%	30%	256%	-16%	-2%	-22%	0%	0%	-107%	2%

Ratios

Consolidated / View Standalone

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	19,953.33	3,325.56	13.04	30.42	52.14		21.47	40.56	60.83	15.87	14.04	17.38
Inventory Days				365.00	365.00	1,460.00	121.67		156.43
Days Payable				5,018.75	3,528.33	13,870.00	1,460.00		1,199.29
Cash Conversion Cycle	19,953.33	3,325.56	13.04	-4,623.33	-3,111.19		-1,316.86	40.56	-982.02	15.87	14.04	17.38
Working Capital Days	-8,528.83	-16,019.44	-14,339.29	-39,967.50	-62,519.29		-29,092.65	-34,593.89	-57,365.83	-15,933.04	-16,509.23	-21,361.19
ROCE %	-8.83%	-10.86%	-14.69%	-10.97%	-17.91%	-22.11%	-26.56%	-32.31%	-20.01%	-2.07%	-1.75%	-2.36%

Insights

In beta

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Employee Benefit Expense
Rs. Lakhs ・Standalone data

xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx
x,xxx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx
xxx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx
x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	xxx.xx	xxx.xx	xxx.xx	xxx.xx
			x.xx	x.xx	x.xx	x.xx	x.xx	x.xx	x.xx

Please log in to see hidden values.

Intangible Assets Under Development
Rs. Lakhs ・Standalone data

Property, Plant and Equipment (Net Block)
Rs. Lakhs ・Standalone data

Technology Intangible Assets (Net Book Value)
Rs. Lakhs ・Standalone data

Patent Application Filing Fees
Rs. Lakhs ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
	23.64%	23.64%	23.64%	23.64%	23.64%	23.64%	23.64%	23.64%	23.64%	23.64%	23.64%	23.64%
	76.36%	76.36%	76.36%	76.37%	76.37%	76.38%	76.37%	76.37%	76.37%	76.37%	76.37%	76.37%
No. of Shareholders	12,220	12,426	12,766	12,963	13,307	13,583	13,475	13,461	13,545	13,767	13,817	13,775

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Sep 2026
	23.64%	23.64%	23.64%	23.64%	23.64%	23.64%	23.64%	23.64%	23.64%	23.64%	23.64%
	76.36%	76.36%	76.36%	76.36%	76.36%	76.36%	76.36%	76.36%	76.38%	76.37%	76.37%
No. of Shareholders	11,387	10,744	10,704	10,415	10,337	11,317	11,371	12,426	13,583	13,767	13,775

Documents

Announcements

All

Transgene Biotek Ltd

Transgene Biotek Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Insights

Shareholding Pattern

Documents

Announcements

Annual reports